After Hours
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours.
Stocks Info
The company is listed on the NASDAQ and operates within the Diagnostics & Research industry segment. The current market capitalization of Neogenomics Inc is $806.08M. A total of 1.83 million shares were traded on the day, compared to an average of 2.23M shares.
In the most recent transaction, Sherman Jeffrey Scott bought 20,000 shares of NEO for 5.62 per share on Aug 06 ’25. After the transaction, the Chief Financial Officer now owns 188,332 company shares. In a previous transaction on Aug 06 ’25, Zook Anthony P. bought 17,900 shares at 5.58 per share. NEO shares that Chief Executive Officer owns now total 38,066.
Among the insiders who bought shares, Kelly Michael Aaron acquired of 5,000 shares on May 27 ’25 at a per-share price of $7.60. This resulted in the Director holding 5,000 shares of NEO after the transaction. In another insider transaction, Stone Warren bought 5,700 shares at $8.58 per share on May 12 ’25. Company shares held by the Pres & Chief Operating Officer now total 108,280.
It has been observed that price targets are rarely accurate, but they can exert some influence from time to time, and are often accepted as valuable in the market. In terms of 52-week highs and lows, NEO has a high of $19.11 and a low of $4.72.
As of this writing, NEO has an earnings estimate of $0.02 per share for the current quarter. EPS was calculated based on a consensus of 13.0 estimates, with a high estimate of $0.05 per share and a lower estimate of $0.01. The company reported an EPS of $0.05 in the last quarter
Balance Sheet Annually/Quarterly
An equity investor’s investment can be viewed on a balance sheet by looking at what assets and liabilities the company has. Investors can determine the company’s prospects by calculating its financial ratios based on this information. NEO’s latest balance sheet shows that the firm has $515.39M in Cash & Short Term Investments as of fiscal 2021. There were $612.79M in debt and $87.23M in liabilities at the time. Its Book Value Per Share was $6.64, while its Total Shareholder’s Equity was $1.11B.
Analysts Opinion
There may be slightly higher risks associated with pre-market and after-hours trading than during regular market hours. Due to the fact that issuers often announce critical financial information outside of regular trading hours, extended-hours trading may result in wider spreads for particular securities. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for NEO is Buy with a score of 3.87.
